About me
Dr. Ji Guo is a chemist in the Office of Policy for Pharmaceutical Quality (OPPQ) within the Office of Pharmaceutical Quality (OPQ) at the FDA's Center for Drug Evaluation and Research (CDER). Her work encompasses scientific review of drug quality issues, policy analysis, and collaboration with internal and external stakeholders on quality matters. She also serves as the FDA Government Liaison to the United States Pharmacopeia (USP). Dr. Guo began her FDA career in 2008 as a research scientist in the Center for Devices and Radiological Health (CDRH). In 2018, she transitioned to CDER to focus on drug product quality. She received her doctoral degree in chemistry from the University of North Carolina at Chapel Hill.
